Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001062993-23-020924

Options or other derivatives

  • Chief Operations Officer acquired 7,269.97 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kurtoglu Metin Chief Operations Officer 2023-11-13 Grant or award · Stock Option (Right to Buy) +6,414.68 6,414.68 D
Kurtoglu Metin Chief Operations Officer 2023-11-13 Grant or award · Stock Option (Right to Buy) +427.65 427.65 D
Kurtoglu Metin Chief Operations Officer 2023-11-13 Grant or award · Stock Option (Right to Buy) +427.65 427.65 D
Loading xslF345X05/form4.xml…